Literature DB >> 14531072

Inhibition of the activity of recombinant HIV-1 integrase by derivatives of higher terpenoids.

E A Semenova1, O A Plyasunova, N I Petrenko, N V Uzenkova, E E Shul'ts, G A Tolstikov, A G Pokrovskii.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14531072     DOI： 10.1023/a:1025113525466

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  11 in total

1.  What can be Expected from Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) in the Treatment of Human Immunodeficiency Virus Type 1 (HIV-1) Infections?

Authors: 
Journal:  Rev Med Virol       Date:  1996-06       Impact factor: 6.989

2.  In vitro assays for activities of retroviral integrase.

Authors:  S A Chow
Journal:  Methods       Date:  1997-08       Impact factor: 3.608

3.  Preliminary evidence for inhibitory effect of glycyrrhizin on HIV replication in patients with AIDS.

Authors:  T Hattori; S Ikematsu; A Koito; S Matsushita; Y Maeda; M Hada; M Fujimaki; K Takatsuki
Journal:  Antiviral Res       Date:  1989 Jun-Jul       Impact factor: 5.970

Review 4.  The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.

Authors:  A S Fauci
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

5.  Human immunodeficiency virus type 1 cDNA integration: new aromatic hydroxylated inhibitors and studies of the inhibition mechanism.

Authors:  C M Farnet; B Wang; M Hansen; J R Lipford; L Zalkow; W E Robinson; J Siegel; F Bushman
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

6.  Betulinic acid derivatives: a new class of specific inhibitors of human immunodeficiency virus type 1 entry.

Authors:  F Soler; C Poujade; M Evers; J C Carry; Y Hénin; A Bousseau; T Huet; R Pauwels; E De Clercq; J F Mayaux; J B Le Pecq; N Dereu
Journal:  J Med Chem       Date:  1996-03-01       Impact factor: 7.446

7.  Sesquiterpenes and alkaloids from Lindera chunii and their inhibitory activities against HIV-1 integrase.

Authors:  Chao-feng Zhang; Norio Nakamura; Supinya Tewtrakul; Masao Hattori; Qi-shi Sun; Zheng-tao Wang; Tamio Fujiwara
Journal:  Chem Pharm Bull (Tokyo)       Date:  2002-09       Impact factor: 1.645

8.  Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells.

Authors:  J F Mayaux; A Bousseau; R Pauwels; T Huet; Y Hénin; N Dereu; M Evers; F Soler; C Poujade; E De Clercq
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

9.  Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV).

Authors:  M Ito; A Sato; K Hirabayashi; F Tanabe; S Shigeta; M Baba; E De Clercq; H Nakashima; N Yamamoto
Journal:  Antiviral Res       Date:  1988-12-11       Impact factor: 5.970

10.  [The anti-HIV activity of beta-glycyrrhizic acid].

Authors:  O A Pliasunova; I N Egoricheva; N V Fediuk; A G Pokrovskiĭ; L A Baltina; Iu I Murinov; G A Tolstikov
Journal:  Vopr Virusol       Date:  1992 Sep-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.